1046 related articles for article (PubMed ID: 26432359)
1. Breast conservative surgery and local recurrence.
Rezai M; Kraemer S; Kimmig R; Kern P
Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
[TBL] [Abstract][Full Text] [Related]
2. Positive Margins After Oncoplastic Surgery for Breast Cancer.
Clough KB; Gouveia PF; Benyahi D; Massey EJ; Russ E; Sarfati I; Nos C
Ann Surg Oncol; 2015 Dec; 22(13):4247-53. PubMed ID: 25893409
[TBL] [Abstract][Full Text] [Related]
3. Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates.
Crown A; Wechter DG; Grumley JW
Ann Surg Oncol; 2015 Oct; 22(10):3363-8. PubMed ID: 26208579
[TBL] [Abstract][Full Text] [Related]
4. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
van Deurzen CH
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
[TBL] [Abstract][Full Text] [Related]
7. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
8. The outcome of oncoplastic techniques in defect reconstruction after resection of central breast tumors.
Farouk O; Attia E; Roshdy S; Khater A; Senbe A; Fathi A; Hamed EE; Mesbah M; Shehatto F; El-Saed A; Denewer A
World J Surg Oncol; 2015 Sep; 13():285. PubMed ID: 26409877
[TBL] [Abstract][Full Text] [Related]
9. Prediction of positive resection margins in patients with non-palpable breast cancer.
Barentsz MW; Postma EL; van Dalen T; van den Bosch MA; Miao H; Gobardhan PD; van den Hout LE; Pijnappel RM; Witkamp AJ; van Diest PJ; van Hillegersberg R; Verkooijen HM
Eur J Surg Oncol; 2015 Jan; 41(1):106-12. PubMed ID: 25228054
[TBL] [Abstract][Full Text] [Related]
10. HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.
Jia H; Jia W; Yang Y; Li S; Feng H; Liu J; Rao N; Jin L; Wu J; Gu R; Zhu L; Chen K; Deng H; Zeng Y; Liu Q; Song E; Su F
World J Surg Oncol; 2014 Sep; 12():289. PubMed ID: 25241216
[TBL] [Abstract][Full Text] [Related]
11. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
Atalay C; Irkkan C
Breast J; 2012; 18(4):339-44. PubMed ID: 22616572
[TBL] [Abstract][Full Text] [Related]
13. A comparison of intra-operative margin management techniques in breast-conserving surgery: a standardised approach reduces the likelihood of residual disease without increasing operative time.
Bolger JC; Solon JG; Khan SA; Hill AD; Power CP
Breast Cancer; 2015 May; 22(3):262-8. PubMed ID: 23649303
[TBL] [Abstract][Full Text] [Related]
14. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
15. Long-term Results After Oncoplastic Surgery for Breast Cancer: A 10-year Follow-up.
Clough KB; van la Parra RFD; Thygesen HH; Levy E; Russ E; Halabi NM; Sarfati I; Nos C
Ann Surg; 2018 Jul; 268(1):165-171. PubMed ID: 28448389
[TBL] [Abstract][Full Text] [Related]
16. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
Sharma SD; Barry M; O'Reilly EA; Kell MR
Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
[TBL] [Abstract][Full Text] [Related]
18. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
[TBL] [Abstract][Full Text] [Related]
19. Short term safety of oncoplastic breast conserving surgery for larger tumors.
Wijgman DJ; Ten Wolde B; van Groesen NR; Keemers-Gels ME; van den Wildenberg FJ; Strobbe LJ
Eur J Surg Oncol; 2017 Apr; 43(4):665-671. PubMed ID: 28041648
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
